Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 27, 2026
Viavi Solutions (VIAV) Slides -21% in 30 Days: Unpacking the Sell-Off

Viavi Solutions (VIAV) Slides -21% in 30 Days: Unpacking the Sell-Off

Key Takeaways

  • Viavi Solutions (VIAV) shares have fallen approximately 21% over the last 30 days, dropping from $47.63 on June 26, 2026, to $37.52 as of July 27, amid a broad technology-sector rout and mounting macroeconomic headwinds.
  • The sell-off accelerated following a Weiss Ratings downgrade to D+ (Sell) on July 16, compounded by the expiration of lockup agreements tied to the company's $500 million equity offering in May.
  • Over the last quarter, the stock declined roughly 17%, retreating sharply from its 52-week high of $60.43 reached on April 30, 2026, just after the company reported strong fiscal Q3 results.
  • Underlying business fundamentals remain robust — Q3 revenue surged 42.8% year-over-year — with AI data center demand, the Spirent acquisition, and aerospace and defense contracts providing structural tailwinds.
  • Investors now look to the August 5, 2026 fiscal fourth-quarter earnings release as a pivotal event that could either stabilize sentiment or extend the downturn.

Understanding Viavi Solutions' Business and Market Position

Viavi Solutions Inc. is a global provider of network test, monitoring, and assurance solutions serving telecommunications carriers, cloud providers, enterprises, military and aerospace operators, and critical infrastructure networks across the Americas, Asia-Pacific, Europe, the Middle East, and Africa. Headquartered in Chandler, Arizona, and founded in 1923 (formerly JDS Uniphase Corporation), the company operates through two segments: Network and Service Enablement (NSE) and Optical Security and Performance Products (OSP). The NSE segment delivers testing, monitoring, assurance, and security solutions for wireless, wireline, cloud, satellite, and public safety networks, while OSP leverages proprietary optical coating technologies for anti-counterfeiting, 3D sensing, government and aerospace, automotive, and industrial markets. Viavi's decades of expertise in precision optical manufacturing, deep relationships with government and defense customers, and a growing portfolio of AI-data-center-focused testing products position the company at the intersection of multiple secular growth themes.

Recent Stock Performance: 30 Days Versus the Quarter

Over the last 30 days, VIAV shares declined approximately 21.2%, falling from a closing price of $47.63 on June 26, 2026, to $37.52 on July 27. The descent was not linear — the stock experienced sharp drops on July 2 and July 16, punctuated by short-lived recoveries, indicating a volatile tape driven more by macro sentiment and technical pressures than by company-specific deterioration. Over the last quarter, the stock has retreated roughly 17% from its late-April levels, a stark reversal from the euphoria that followed the company's fiscal Q3 earnings beat on April 29. The 52-week range tells a dramatic story: VIAV traded as high as $60.43 on April 30, 2026, and as low as $9.62 within the same period, underscoring the stock's extreme volatility and the rapid compression of its valuation premium. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Factors Behind the 30-Day Decline

Several converging factors fueled the 30-day decline. First, the broader technology and communication-services sectors faced heavy selling pressure in late July after the Nasdaq suffered its worst single-day drop in roughly a month. The rout was triggered by Alphabet (GOOGL) disclosing a major expansion of AI spending plans and Tesla (TSLA) reporting a sharp operating-profit miss, which rattled confidence in high-multiple growth names. Second, macro conditions deteriorated concurrently: oil prices surged above $100 per barrel following attacks on Saudi oil tankers, the U.S. imposed new tariffs on goods from 60 trading partners, and stubborn inflation pushed back expectations for Federal Reserve rate cuts. Third, VIAV-specific pressures amplified the sell-off. On July 16, Weiss Ratings downgraded the stock to D+ (Sell), citing negative GAAP profitability and a forward P/E that appeared stretched relative to earnings generation. The expiration of lockup agreements on approximately 234 million shares on July 19 — tied to the company's $500 million equity offering at $45 per share in May — raised concerns about potential insider selling, a worry validated by $26.5 million in insider stock sales over the prior three months.

Quarterly Downtrend and Market Context

The quarterly downtrend reflects a broader repricing of risk across high-valuation technology stocks rather than a breakdown in Viavi's operational trajectory. The stock peaked at $60.43 on April 30, the day after the company reported fiscal Q3 revenue of $406.8 million, up 42.8% year-over-year, and non-GAAP EPS of $0.27, which exceeded consensus estimates. Despite these strong results, the post-earnings spike proved unsustainable as investors rotated away from richly valued names — VIAV traded at 7.7 times sales at its peak. The May equity offering, while strategically aimed at retiring high-cost debt, diluted existing shareholders and introduced a substantial overhang that contributed to choppy trading through June. Meanwhile, the NSE segment continued benefiting from surging data center interconnect (DCI) demand tied to AI infrastructure buildouts, with analysts at Susquehanna raising their price target to $66 on July 1. However, positive fundamental developments were overwhelmed by macro-driven risk aversion, tariff escalation fears, and sector-wide repositioning as the quarter progressed.

What to Watch Next for VIAV

The most critical near-term event for VIAV shareholders is the company's fiscal fourth-quarter and full-year 2026 earnings report, scheduled for August 5, 2026, after market close. Management previously guided for Q4 revenue of $427 million to $437 million and non-GAAP EPS of $0.29 to $0.31 — any shortfall in a macro environment already strained by tariff risk and delayed Fed easing could accelerate the stock's retreat from April highs. Beyond the earnings print, investors should monitor whether AI-driven data center interconnect demand continues translating into sustained NSE segment growth, particularly from key customers such as Nokia (NOK) and Ciena (CIEN). The integration and cross-selling progress from the Spirent Ethernet and network security business acquisition, the trajectory of operating margin expansion, and any further insider selling activity will also serve as important sentiment barometers. Macroeconomic factors — including tariff policy developments, oil price trends, and Federal Reserve interest rate decisions — remain external variables capable of overshadowing company-specific progress in the weeks ahead.

Using AI Tools to Navigate Volatile Markets

In volatile market environments like the one currently affecting VIAV, I often look at Tickeron's Trending AI Robots page for additional perspective. It highlights a selection of top-performing AI-powered trading bots across different styles and holding periods, which can help complement traditional analysis when assessing opportunities in challenging conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VIAV

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


VIAV in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 28, 2026

VIAV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where VIAV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where VIAV's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VIAV just turned positive on August 04, 2026. Looking at past instances where VIAV's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VIAV advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIAV as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIAV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VIAV entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VIAV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.911) is normal, around the industry mean (7.398). VIAV's P/E Ratio (350.500) is considerably higher than the industry average of (66.974). VIAV's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.193). VIAV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (6.135) is also within normal values, averaging (14.445).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Cisco Systems (NASDAQ:CSCO), Hewlett Packard Enterprise Company (NYSE:HPE), Lumentum Holdings (NASDAQ:LITE), Ciena Corp (NYSE:CIEN), Nokia Corp (NYSE:NOK), Ericsson (NASDAQ:ERIC).

Industry description

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

Market Cap

The average market capitalization across the Telecommunications Equipment Industry is 21.85B. The market cap for tickers in the group ranges from 1.59K to 478.88B. CSCO holds the highest valuation in this group at 478.88B. The lowest valued company is ABILF at 1.59K.

High and low price notable news

The average weekly price growth across all stocks in the Telecommunications Equipment Industry was 10%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 26%. CLRO experienced the highest price growth at 127%, while INSG experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Telecommunications Equipment Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 53
Price Growth Rating: 48
SMR Rating: 74
Profit Risk Rating: 76
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
VIAV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of network infrastructure software and hardware solutions

Industry TelecommunicationsEquipment

Profile
Details
Industry
Electronic Equipment Or Instruments
Address
1445 South Spectrum Boulevard
Phone
+1 408 404-3600
Employees
3600
Web
https://www.viavisolutions.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.